These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32503466)

  • 21. Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma.
    Kashimoto K; Komatsu S; Ichikawa D; Arita T; Konishi H; Nagata H; Takeshita H; Nishimura Y; Hirajima S; Kawaguchi T; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Cancer Sci; 2012 Nov; 103(11):2021-6. PubMed ID: 22862969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma.
    Kawaguchi T; Komatsu S; Ichikawa D; Hirajima S; Nishimura Y; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Tumour Biol; 2017 Jun; 39(6):1010428317700409. PubMed ID: 28618928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High TRIM44 expression in endometrial carcinoma is associated with a poorer patient outcome.
    Li P; Yin H; Meng F; Liu S; Liu H; Ma R
    Pathol Res Pract; 2018 May; 214(5):727-731. PubMed ID: 29526558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and clinicopathological significance of TRIM21 in various cancers: A meta and bioinformatic analysis.
    Hu F; Liu Y; Wang F; Fu X; Liu X; Zou Z; Zhou B
    Medicine (Baltimore); 2023 Jun; 102(23):e34012. PubMed ID: 37335642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of TRIM44 is an independent marker for predicting poor prognosis in epithelial ovarian cancer.
    Liu S; Yin H; Ji H; Zhu J; Ma R
    Exp Ther Med; 2018 Oct; 16(4):3034-3040. PubMed ID: 30214522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
    Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic and clinicopathological significance of SNHG6 in human cancers: a meta-analysis.
    Zhao S; Zhu H; Jiao R; Wu X; Ji G; Zhang X
    BMC Cancer; 2020 Jan; 20(1):77. PubMed ID: 32000704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-34a-5p directly targeting TRIM44 affects the biological behavior of ovarian cancer cells.
    Li HL; Duan YA; Zhao N
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1250-1260. PubMed ID: 33629295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis.
    Li C; Liu T; Yin L; Zuo D; Lin Y; Wang L
    Medicine (Baltimore); 2019 Mar; 98(9):e14659. PubMed ID: 30817589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINC00511 as a prognostic biomarker for human cancers: a systematic review and meta-analysis.
    Agbana YL; Abi ME; Ni Y; Xiong G; Chen J; Yun F; Yi Z; Zhang Q; Yang Z; Kuang Y; Zhu Y
    BMC Cancer; 2020 Jul; 20(1):682. PubMed ID: 32698787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of HOXB7 is an unfavorable prognostic factor for solid malignancies: A meta-analysis.
    Zhou T; Feng Z; Yang F; Zhu W; Cao J; Hou X; Zhao Y; Chen D
    Medicine (Baltimore); 2022 Jan; 101(3):e28564. PubMed ID: 35060516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma.
    Zhu X; Wu Y; Miao X; Li C; Yin H; Yang S; Lu X; Liu Y; Chen Y; Shen R; Chen X; He S
    Tumour Biol; 2016 Nov; 37(11):14615-14628. PubMed ID: 27619678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4.
    Wei CY; Wang L; Zhu MX; Deng XY; Wang DH; Zhang SM; Ying JH; Yuan X; Wang Q; Xuan TF; He AQ; Qi FZ; Gu JY
    J Exp Clin Cancer Res; 2019 Mar; 38(1):137. PubMed ID: 30922374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRIM59: A potential diagnostic and prognostic biomarker in human tumors.
    Jin Z; Liu L; Yu Y; Li D; Zhu X; Yan D; Zhu Z
    PLoS One; 2021; 16(9):e0257445. PubMed ID: 34534244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplification of TRIM44: pairing a prognostic target with potential therapeutic strategy.
    Ong CA; Shannon NB; Ross-Innes CS; O'Donovan M; Rueda OM; Hu DE; Kettunen MI; Walker CE; Noorani A; Hardwick RH; Caldas C; Brindle K; Fitzgerald RC
    J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24777112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of long non-coding RNA DUXAP8 suppresses proliferation, metastasis and EMT by modulating miR-498 through TRIM44-mediated AKT/mTOR pathway in non-small-cell lung cancer.
    Ji X; Tao R; Sun LY; Xu XL; Ling W
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3152-3165. PubMed ID: 32271433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis.
    Zhang G; Cai J
    J BUON; 2019; 24(6):2553-2559. PubMed ID: 31983132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of high stanniocalcin 2 expression in solid cancers: A meta-analysis.
    Hu L; Zha Y; Kong F; Pan Y
    Medicine (Baltimore); 2019 Oct; 98(43):e17432. PubMed ID: 31651846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tripartite Motif-Containing 44 is Involved in the Tumorigenesis of Laryngeal Squamous Cell Carcinoma, and its Expression is Downregulated by Nuciferine.
    Li QH; Sui LP; Zhao YH; Chen BG; Li J; Ma ZH; Hu ZH; Tang YL; Guo YX
    Tohoku J Exp Med; 2021 May; 254(1):17-23. PubMed ID: 34011804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling.
    Peng R; Zhang PF; Zhang C; Huang XY; Ding YB; Deng B; Bai DS; Xu YP
    Cancer Med; 2018 Mar; 7(3):796-808. PubMed ID: 29446253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.